about
Clinical surveillance of thrombotic microangiopathies in Scotland, 2003-2005.Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience.Regionally acquired intestinal failure data suggest an underestimate in national service requirements.An evaluation of enteral nutrition practices and nutritional provision in children during the entire length of stay in critical care.Children, parents and pets exercising together (CPET): exploratory randomised controlled trial.Effects of massage on the mechanical behaviour of muscles in adolescents with spastic diplegia: a pilot study.Effects of tumor staging and treatment modality on functional outcome and quality of life after treatment for laryngeal cancer.Measured versus reported parental height.Neonatal weight loss in breast and formula fed infantsAssessment of secondary haemorrhage rates following adult tonsillectomy--a telephone survey and literature review.A survey of patient preferences for a placebo orodispersible tabletImprovement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979-2003.Severity and management of psoriasis within primary care.Acute B-type natriuretic peptide response and early postoperative right ventricular physiology following tetralogy of Fallot's repair.Femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: Study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery.Severity of non-immune hydrops fetalis at birth continues to predict survival despite advances in perinatal care.Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.The Rotaglide mobile bearing knee arthroplasty A 10- to 13-year review from an independent centre.Retrospective review of diphencyprone in the treatment of alopecia areata.The impact of 12 months treatment with ivacaftor on Scottish paediatric patients with cystic fibrosis with the G551D mutation: a review.Cardiopulmonary exercise testing in children with cystic fibrosis: one centre's experience.Automated identification of Fos expression.Ethinyl estradiol treatment for growth limitation in girls with Marfan's syndrome--experience from a single center.Prevalence of reactive attachment disorder in a deprived population.The use of real-time digital video in the assessment of post-operative outcomes of breast reconstruction.Associations between obesity and cognition in the pre-school years.Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?Colour of bile vomiting in intestinal obstruction in the newborn: questionnaire study.Reliability of a question inventory for structured history taking in children with cerebral visual impairment.The Effect of Socio-Economic Status on Severity of Periocular Basal Cell Carcinoma at Presentation.Presence of free radicals in intracameral agents commonly used during cataract surgery.Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis.Assessing the accuracy of intracameral antibiotic preparation for use in cataract surgery.Reduction in cryptosporidiosis associated with introduction of enhanced filtration of drinking water at Loch Katrine, Scotland.Reversible nasal airway obstruction: does change in nasal peak inspiratory flow following decongestion predict response to topical steroids in chronic rhinosinusitis patients?Cortisol secretion in children with symptoms of reactive attachment disorder.Hypertrophic pyloric stenosis in premature infants: evaluation of sonographic criteria and short-term outcomes.Impact of using national v. international definitions of underweight, overweight and obesity: an example from Kuwait.Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukemia and its association with mineral homeostasis and duration of inpatient stay.
P50
Q33374424-FF84A291-2993-47EA-8D3E-EE5CF7BCB580Q33387966-0E890780-7129-4651-8A3B-103B20AA33DAQ33494782-38DAB335-1023-41F6-B679-89E3A906EABCQ33957413-B2D9DE8C-FB4F-4462-A823-3B2E3BA832DDQ34464029-B8F6B1C6-1F5B-4E6E-AA8B-2743303B661AQ34577515-4215E3B9-500F-4997-8615-C6083F945BDFQ34618165-E00F6FE1-169E-4AFA-A9A0-79E9D904EF15Q35284921-148086F4-3AC0-4EBF-8ED0-94D48338DE52Q35571689-F7E94B43-D450-4286-9D86-7B9DC06CD153Q35583289-9993883C-1DA8-417E-AA6A-0D8DDCB760D2Q35905934-5F7B3B31-DAEE-4891-A21F-F58512532C20Q36153579-EDC390EA-E775-44D0-94D0-347DD03DA8B9Q36163078-002B7FAC-ACAB-4EC4-8F0E-F80EDCC2EB7BQ36175452-671893B3-793A-4B25-813F-FB9DD0D3B88BQ36231881-D529BEB4-F89B-4A1C-A12B-F2A8E1FC8313Q36498950-7BF02F04-F5B3-42E7-9D44-D33BA222EA2FQ37394146-95AC9F38-0816-44B4-9FAA-B8967AF500E8Q37826981-603E0F17-6561-430D-BFD7-DAB4928016E2Q38653765-8841C931-D291-46EE-86D9-BD8C39008EA0Q38861987-7442DBA8-3E7B-4028-B2EF-C5CB8AB2AF85Q39029958-4B2852A6-88D6-4C69-90CE-1E025136015BQ39658075-D086EB73-D41B-45FE-83F0-49A04BE44291Q39933724-6DF834DA-9CC8-4289-B705-C915A6CAFA5BQ40104706-194B56E8-FF5B-4C48-AD72-109047318B0AQ40200084-6316CEE9-8EA5-46FB-ADD5-F9F116E5D8B3Q41072503-A243FF1E-5358-42A4-B0A5-FA1A9499B6ECQ42040480-53874341-1250-4C77-A448-EE4E4CDCBA9BQ42412692-31B1EA35-2F36-4BC1-8390-F7D69BCBBDAFQ42428082-197F00E4-2F46-4B53-B39B-B6E49093BD4DQ42473446-46AAFD6E-DB64-43E1-BF60-F8D7A0D65309Q42965319-2889A103-6A61-4C5C-9F9E-F634F2638DDEQ43006219-6CAF205D-437F-478E-99B6-9F2676851E22Q43053152-B18D714B-A94F-4D2D-99FE-3F4E108DCEE1Q43163625-07A93FEF-9C3A-45D1-A881-25AF2EB18B24Q43357687-AF60D2D1-4F10-465C-852D-B2D87D21E105Q43543943-E8036453-B811-4B53-AF22-9F8A6CA45445Q43588572-C4850986-6A76-44F0-8954-E33CE7A9E537Q43609537-076D946F-4C0D-458B-9DB5-2ABC58D25DB2Q44050705-D39C84B7-CA6D-46E3-A229-6FECA73DFCA7Q44107606-07AFA4C4-EB70-4067-BA0D-5C93724C5D8F
P50
description
researcher ORCID: 0000-0002-3652-0513
@en
name
David Young
@ast
David Young
@en
David Young
@es
David Young
@nl
David Young
@sl
type
label
David Young
@ast
David Young
@en
David Young
@es
David Young
@nl
David Young
@sl
prefLabel
David Young
@ast
David Young
@en
David Young
@es
David Young
@nl
David Young
@sl
P106
P1153
14061376200
56921110100
P21
P31
P496
0000-0002-3652-0513